Identification of Preferred Chemotherapeutics for Combining With a CHK1 Inhibitor

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity

Scientific Reports
Multidisciplinary
2016English

γH2AX and Chk1 Phosphorylation as Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-Chemotherapy Combination Treatments

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

A Multivariable Model for Identification of Preferred Location of Wind Plants

Renewable Energy and Power Quality Journal
Electronic EngineeringEnergy EngineeringRenewable EnergySustainabilityElectricalPower Technologythe Environment
2008English

Combining Ketamine With Astrocytic Inhibitor as a Potential Analgesic Strategy for Neuropathic Pain. Ketamine, Astrocytic Inhibitor and Pain

Molecular Pain
Molecular MedicineAnesthesiologyPain MedicineCellularMolecular Neuroscience
2010English

Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells

Oncotarget
Oncology
2016English

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor With a Unique Specificity for a Rodent SAMD9L

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy